The payback system for medical devices, initially applied to medicines, is straining healthcare companies and risking service reductions for patients. With a cap of 4.4% on public spending, companies face significant financial burdens, particularly in regions like Marche, where over 40 firms must contribute 136 million euros. Experts call for a revision of spending ceilings and improved governance to ensure the procurement of safe, efficient technologies while controlling public expenditure.